190 related articles for article (PubMed ID: 25864879)
41. RNA G-quadruplex as supramolecular carrier for cancer-selective delivery.
Santos T; Pereira P; Campello MPC; Paulo A; Queiroz JA; Cabrita E; Cruz C
Eur J Pharm Biopharm; 2019 Sep; 142():473-479. PubMed ID: 31325486
[TBL] [Abstract][Full Text] [Related]
42. Duplex/quadruplex oligonucleotides: Role of the duplex domain in the stabilization of a new generation of highly effective anti-thrombin aptamers.
Russo Krauss I; Napolitano V; Petraccone L; Troisi R; Spiridonova V; Mattia CA; Sica F
Int J Biol Macromol; 2018 Feb; 107(Pt B):1697-1705. PubMed ID: 29024684
[TBL] [Abstract][Full Text] [Related]
43. The influencing factors and functions of DNA G-quadruplexes.
Yuan WF; Wan LY; Peng H; Zhong YM; Cai WL; Zhang YQ; Ai WB; Wu JF
Cell Biochem Funct; 2020 Jul; 38(5):524-532. PubMed ID: 32056246
[TBL] [Abstract][Full Text] [Related]
44. AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
Figueiredo J; Lopes-Nunes J; Carvalho J; Antunes F; Ribeiro M; Campello MPC; Paulo A; Paiva A; Salgado GF; Queiroz JA; Mergny JL; Cruz C
Int J Pharm; 2019 Sep; 568():118511. PubMed ID: 31301466
[TBL] [Abstract][Full Text] [Related]
45. G-quadruplex DNA aptamers and their ligands: structure, function and application.
Tucker WO; Shum KT; Tanner JA
Curr Pharm Des; 2012; 18(14):2014-26. PubMed ID: 22376117
[TBL] [Abstract][Full Text] [Related]
46. AS1411 Aptamer/Hyaluronic Acid-Bifunctionalized Microemulsion Co-Loading Shikonin and Docetaxel for Enhanced Antiglioma Therapy.
Wang H; Zhu Z; Zhang G; Lin F; Liu Y; Zhang Y; Feng J; Chen W; Meng Q; Chen L
J Pharm Sci; 2019 Nov; 108(11):3684-3694. PubMed ID: 31465736
[TBL] [Abstract][Full Text] [Related]
47. Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549).
Coyne CP; Narayanan L
Anticancer Agents Med Chem; 2019; 19(6):802-819. PubMed ID: 30514195
[TBL] [Abstract][Full Text] [Related]
48. Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers.
Abnous K; Danesh NM; Ramezani M; Charbgoo F; Bahreyni A; Taghdisi SM
Expert Opin Drug Deliv; 2018 Nov; 15(11):1045-1052. PubMed ID: 30269603
[TBL] [Abstract][Full Text] [Related]
49. Thrombin binding aptamer analogues containing inversion of polarity sites endowed with antiproliferative and anti-motility properties against Calu-6 cells.
Esposito V; Russo A; Vellecco V; Bucci M; Russo G; Mayol L; Virgilio A; Galeone A
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2645-2650. PubMed ID: 30071274
[TBL] [Abstract][Full Text] [Related]
50. Multi-targeted effects of G4-aptamers and their antiproliferative activity against cancer cells.
Ogloblina AM; Khristich AN; Karpechenko NY; Semina SE; Belitsky GA; Dolinnaya NG; Yakubovskaya MG
Biochimie; 2018 Feb; 145():163-173. PubMed ID: 29208488
[TBL] [Abstract][Full Text] [Related]
51. Novel roles of ginsenoside Rg3 in apoptosis through downregulation of epidermal growth factor receptor.
Joo EJ; Chun J; Ha YW; Ko HJ; Xu MY; Kim YS
Chem Biol Interact; 2015 May; 233():25-34. PubMed ID: 25824408
[TBL] [Abstract][Full Text] [Related]
52. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
[TBL] [Abstract][Full Text] [Related]
53. General cell-binding activity of intramolecular G-quadruplexes with parallel structure.
Chang T; Qi C; Meng J; Zhang N; Bing T; Yang X; Cao Z; Shangguan D
PLoS One; 2013; 8(4):e62348. PubMed ID: 23638046
[TBL] [Abstract][Full Text] [Related]
54. Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: the versatile adjuvant for gefitinib therapy.
Lee JY; Lee YM; Chang GC; Yu SL; Hsieh WY; Chen JJ; Chen HW; Yang PC
PLoS One; 2011; 6(8):e23756. PubMed ID: 21858220
[TBL] [Abstract][Full Text] [Related]
55. Discovery and development of anticancer aptamers.
Ireson CR; Kelland LR
Mol Cancer Ther; 2006 Dec; 5(12):2957-62. PubMed ID: 17172400
[TBL] [Abstract][Full Text] [Related]
56. NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
Del Valle AC; Su CK; Sun YC; Huang YF
Biomater Sci; 2020 Mar; 8(7):1934-1950. PubMed ID: 32039412
[TBL] [Abstract][Full Text] [Related]
57. Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.
Rajabnejad SH; Mokhtarzadeh A; Abnous K; Taghdisi SM; Ramezani M; Razavi BM
Drug Dev Ind Pharm; 2018 Jun; 44(6):982-987. PubMed ID: 29325460
[TBL] [Abstract][Full Text] [Related]
58. Multifunctional G-quadruplex aptamers and their application to protein detection.
Li T; Shi L; Wang E; Dong S
Chemistry; 2009; 15(4):1036-42. PubMed ID: 19053089
[TBL] [Abstract][Full Text] [Related]
59. Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential.
Gatto B; Palumbo M; Sissi C
Curr Med Chem; 2009; 16(10):1248-65. PubMed ID: 19355883
[TBL] [Abstract][Full Text] [Related]
60. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
